Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172564 | SCV000050991 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Blueprint Genetics | RCV000208173 | SCV000264069 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2015-03-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000821750 | SCV000962519 | uncertain significance | Hypertrophic cardiomyopathy 14 | 2023-12-17 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 864 of the MYH6 protein (p.Thr864Met). This variant is present in population databases (rs200153625, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MYH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 192122). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYH6 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000172564 | SCV002526487 | uncertain significance | not provided | 2022-06-09 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23861362) |
Ambry Genetics | RCV002433759 | SCV002745411 | uncertain significance | Cardiovascular phenotype | 2022-11-15 | criteria provided, single submitter | clinical testing | The p.T864M variant (also known as c.2591C>T), located in coding exon 19 of the MYH6 gene, results from a C to T substitution at nucleotide position 2591. The threonine at codon 864 is replaced by methionine, an amino acid with similar properties. This variant has been detected in a case with hypoplastic left heart syndrome (Theis JL et al. Circ Genom Precis Med. 2021 02;14(1):e003126). This variant has also been reported as a secondary cardiac variant in an exome cohort (Ng D et al. Circ Cardiovasc Genet, 2013 Aug;6:337-46). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Dept of Medical Biology, |
RCV003318361 | SCV004021989 | uncertain significance | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: Not met |
Ce |
RCV000172564 | SCV005093361 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | MYH6: BP4, BS2 |